Vici Health Exhibiting at 23rd Annual Contract Pharma in New Brunswick, NJ
Vici Health Sciences is exhibiting at the 23rd Annual Contract Pharma Conference on September 26-27 at the Hyatt Regency, New Brunswick, NJ. Our founder and CEO, Dr. Anish Dhanarajan, will be in attendance to discuss and answer questions on how Vici can provide high quality, cost-effective drug development solutions for your pharmaceutical programs. Visit us […]
Vici Health Sciences Attending 2024 Chem Outsourcing Conference in Parsippany, NJ
Vici Health Sciences will be attending the 2024 Chem Outsourcing Conference on Thursday, September 5th, 2024 in Parsippany, NJ. Date: September 5th from 7am-6pmLocation: Hilton ParsippanyAddress: 1 Hilton Ct, Parsippany, NJ 07054 This is a great opportunity to meet with our founder and CEO, Dr. Anish Dhanarajan, to discuss how Vici can provide formulation development, […]
Meet with Vici at AAPS 2023 PharmSci 360
Are you looking for a high quality, US-based, full service R&D focused CDMO to accelerate your drug development program? Meet with our CEO, Dr Anish Dhanarajan and Senior Director of R&D, Dr Suneel Rastogi at AAPS next week to discuss your needs. Vici offers cGMP API synthesis for nonclinical and phase 1 clinical studies, formulation development services for a variety of […]
Vici Health to exhibit at the 22nd Annual Contract Pharma Conference September 21-22, 2023
Vici will be exhibiting at the 22nd Annual Contract Pharma Conference September 21-22, 2023 Hyatt Regency, New Brunswick NJ. As a proud Gold Level Sponsor of the event, Vici invites you to Table 101 to understand your pharmaceutical R&D needs and discuss how we may help grow your drug development pipeline.
Vici offers phase 1, phase 2, and phase 3 clinical supplies manufacturing services
Through strong partnerships with our sister manufacturing company, Vici is now able to provide Phase 3 clinical manufacturing services to support NDA programs. With this offering, Vici is able to offer a full range of integrated CDMO services starting from early phase cGMP API synthesis to support nonclinical toxicology and proof-of-concept studies, first-in-human formulation development […]
Vici is excited to announce that Dr Suneel Rastogi will be joining our technical leadership team.
Dr. Rastogi has over 24 years of extensive experience in the development of a variety of conventional and complex dosage forms including oral dosage forms, injectables, long acting, amorphous solid dispersions, ophthalmic, topical, nano particulates, peptides, nasal sprays and rectal gels. He has a proven track record of successfully managing over 100 internal and external […]
Vici Health exhibiting at the CPHI North America Conference in Philadelphia, Pennsylvania April 25-27, 2023
Vici Health, a world class pharmaceutical product development company, announced that it will be exhibiting at the CPHI North America Conference in Philadelphia, Pennsylvania April 25-27, 2023. Based in Maryland, USA, Vici provides CDMO services that include API synthesis, formulation development, analytical development and testing, phase 1 and 2 cGMP clinical supplies manufacturing, and Regulatory/CMC […]
Vici Health Sciences Expands Staff and Footprint in Maryland
ELKRIDGE, MD. (PRWEB) DECEMBER 31, 2019 Vici Health Sciences announces it is breaking ground in expanding its pharmaceutical product development lab in Maryland. Emphasis will be in expanding capabilities in both oral and parenteral dosage forms. With the increased size and expanded capabilities, Vici Health Sciences will be well positioned to meet the growing demand for its pharmaceutical formulation […]
Vici Health Sciences is announcing its successful completion of initial clinical studies for its 505(b)(2) product pipeline
ELKRIDGE, MD. (PRWEB) DECEMBER 27, 2019 Vici Health Sciences is announcing its successful completion of initial clinical studies for its 505(b)(2) product pipeline that offers patients and healthcare providers options in the treatment of chronic diseases that disproportionately affect geriatric patients. The products concepts were identified in collaboration with doctors and managed care professionals and developed at Vici’s R&D […]